Ultragenyx Pharmaceutical | RARE - Sales Revenues


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical reported $100.5M in Sales Revenues for its fiscal quarter ending in March of 2023.


Sales Change
Acadia Pharmaceuticals ACAD:US USD 118.46M 18.03M
Agios Pharmaceuticals AGIO:US USD 5.61M 1.3M
Alnylam Pharmaceuticals ALNY:US USD 319.29M 15.74M
BioCryst Pharmaceuticals BCRX:US USD 68.78M 10.77M
BioMarin Pharmaceutical BMRN:US USD 596.42M 58.88M
Bluebird Bio BLUE:US USD 2.38M 2.32M
Esperion Therapeutics ESPR:US USD 24.33M 5.51M
Insmed INSM:US USD 65.21M 5.91M
Ionis Pharmaceuticals IONS:US USD 130.52M 21.36M
Karyopharm Therapeutics KPTI:US USD 38.7M 5.12M
Kyowa Hakko Kirin 4151:JP JPY 93.54B 21.06B
MacroGenics MGNX:US USD 24.5M 48.6M
Mirati Therapeutics MRTX:US USD 7.17M 6.23M
Moderna Inc MRNA:US USD 1.86B 3.22B
Neurocrine Biosciences NBIX:US USD 420.4M 8.4M
PTC Therapeutics PTCT:US USD 220.38M 52.97M
Puma Biotechnology PBYI:US USD 52.78M 12.9M
Regeneron Pharmaceuticals REGN:US USD 3.16B 252.3M
Sarepta Therapeutics SRPT:US USD 253.5M 4.93M
Ultragenyx Pharmaceutical RARE:US USD 100.5M 2.85M
Vertex Pharmaceuticals VRTX:US USD 2.37B 72.1M
Xoma XOMA:US USD 437K 1.05M